This page contains brief information about midostaurin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Midostaurin is approved to treat:
- Acute myeloid leukemia (AML). It is used with cytarabine and daunorubicin in newly diagnosed patients whose cancer has a mutation in the FLT3 gene.
- Aggressive systemic mastocytosis, systemic mastocytosis with associated hematologic neoplasm (SM-AHN), or mast cell leukemia.
Midostaurin is also being studied in the treatment of other conditions and types of cancer.
More About Midostaurin
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Midostaurin - Check for trials from NCI's list of cancer clinical trials now accepting patients.